TCI Wealth Advisors’s VALEANT PHARMACEUTICALS INTL VRX Stock Holding History

TCI Wealth Advisors’s Portfolio VRX Stock Details VRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-25	Closed	-$1K	–	1500
2016 Q1	$1K	Buy	+25	New	+$1K	﹤0.01%	1304
2014 Q1	–	Sell	-157	Closed	-$18K	–	950
2013 Q4	$18K	Hold	157	–	–	0.01%	351
2013 Q3	$16K	Buy	157 +126	+406%	+$12.8K	0.01%	317
2013 Q2	$3K	Buy	+31	New	+$3K	﹤0.01%	564

Other funds holding VRX

SIM

Sonora Investment Management Tucson, Arizona $798M AUM 17.61% 1-Year Est. Return

TCI Wealth Advisors's VRX Position: Q2 2016 in Review

TCI Wealth Advisors sold out of VALEANT PHARMACEUTICALS INTL (VRX) in Q2 2016, closing a stake of 25 shares — an estimated $1K sold.

TCI Wealth Advisors first reported a position in VRX in Q2 2013 and held it in 4 quarters. The position peaked at $18K in Q4 2013. 1 fund tracked by Wall St. Rank holds VRX as of Q2 2016.

TCI Wealth Advisors reported no remaining VALEANT PHARMACEUTICALS INTL position as of Q2 2016 after selling out during the quarter.
TCI Wealth Advisors sold 25 VALEANT PHARMACEUTICALS INTL shares in Q2 2016, an estimated $1K.
TCI Wealth Advisors first reported a position in VALEANT PHARMACEUTICALS INTL in Q2 2013 and held it in 4 quarters.
TCI Wealth Advisors's VALEANT PHARMACEUTICALS INTL position peaked at $18K in Q4 2013.
1 fund tracked by Wall St. Rank held VALEANT PHARMACEUTICALS INTL as of Q2 2016.

Based on TCI Wealth Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.